FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 30 20:35
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 25 19:55
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 22 20:05
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 17 20:04
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 17 01:19
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 15 20:08
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 05:01
FSD Pharma | 20-F: Registration statement / Annual report / Transition report
Apr 3 01:16
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 27 20:04
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 11 20:01
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 5 21:02
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 28 21:02
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 26 21:06
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 23 01:20
FSD Pharma | 424B5: Prospectus
Feb 21 01:26
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 20 19:08
FSD Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Feb 20 19:08
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 8 05:07
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 8 05:02
FSD Pharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 16 13:00
No Data
No Data